Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liliya Silayeva

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Science Translational Medicine|January 24, 2020
Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in miceVenkaiah Betapudi, Reena Goswami, Liliya Silayeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2012
Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibitionTija C Jacob, Guido Michels, Liliya Silayeva, et al.
Trends in Neurosciences|October 22, 2013
Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2Kristopher T Kahle, Tarek Z Deeb, Martin Puskarjov, et al.
Frontiers in Oncology|May 10, 2019
Gene Therapy Leaves a Vicious CycleReena Goswami, Gayatri Subramanian, Liliya Silayeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
KCC2 activity is critical in limiting the onset and severity of status epilepticusLiliya Silayeva, Tarek Z Deeb, Rochelle M Hines, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivoSudhir Sivakumaran, Ross A Cardarelli, Jamie Maguire, et al.
EMBO Reports|June 15, 2014
Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsyKristopher T Kahle, Nancy D Merner, Perrine Friedel, et al.
Nature Medicine|December 8, 2017
The small molecule CLP257 does not modify activity of the K<sup>+</sup>-Cl<sup>-</sup> co-transporter KCC2 but does potentiate GABA<sub>A</sub> receptor activityRoss A Cardarelli, Karen Jones, Lucie I Pisella, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Science Translational Medicine|January 24, 2020
Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in miceVenkaiah Betapudi, Reena Goswami, Liliya Silayeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2012
Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibitionTija C Jacob, Guido Michels, Liliya Silayeva, et al.
Trends in Neurosciences|October 22, 2013
Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2Kristopher T Kahle, Tarek Z Deeb, Martin Puskarjov, et al.
Frontiers in Oncology|May 10, 2019
Gene Therapy Leaves a Vicious CycleReena Goswami, Gayatri Subramanian, Liliya Silayeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
KCC2 activity is critical in limiting the onset and severity of status epilepticusLiliya Silayeva, Tarek Z Deeb, Rochelle M Hines, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivoSudhir Sivakumaran, Ross A Cardarelli, Jamie Maguire, et al.
EMBO Reports|June 15, 2014
Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsyKristopher T Kahle, Nancy D Merner, Perrine Friedel, et al.
Nature Medicine|December 8, 2017
The small molecule CLP257 does not modify activity of the K<sup>+</sup>-Cl<sup>-</sup> co-transporter KCC2 but does potentiate GABA<sub>A</sub> receptor activityRoss A Cardarelli, Karen Jones, Lucie I Pisella, et al.
Pageof 1